Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002031753 | SCV002312508 | likely benign | Noonan syndrome 9 | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004044851 | SCV005025574 | uncertain significance | Cardiovascular phenotype | 2024-01-16 | criteria provided, single submitter | clinical testing | The p.N198Y variant (also known as c.592A>T), located in coding exon 5 of the SOS2 gene, results from an A to T substitution at nucleotide position 592. The asparagine at codon 198 is replaced by tyrosine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |